PL2724720T3 - Kompozycje fenylefryny użyteczne do leczenia choroby dróg oddechowych - Google Patents

Kompozycje fenylefryny użyteczne do leczenia choroby dróg oddechowych

Info

Publication number
PL2724720T3
PL2724720T3 PL13187884T PL13187884T PL2724720T3 PL 2724720 T3 PL2724720 T3 PL 2724720T3 PL 13187884 T PL13187884 T PL 13187884T PL 13187884 T PL13187884 T PL 13187884T PL 2724720 T3 PL2724720 T3 PL 2724720T3
Authority
PL
Poland
Prior art keywords
phenylephrine
compositions
useful
treatment
respiratory illness
Prior art date
Application number
PL13187884T
Other languages
English (en)
Inventor
Kelly Lee Martin
Jayant Eknath Khanolkar
Douglas William Gledhill
Susan Elaine Criss
Niranjan Ramji
Elaine Rose Costeines
Original Assignee
The Procter And Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38620207&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2724720(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Procter And Gamble Company filed Critical The Procter And Gamble Company
Publication of PL2724720T3 publication Critical patent/PL2724720T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
PL13187884T 2006-04-21 2007-04-20 Kompozycje fenylefryny użyteczne do leczenia choroby dróg oddechowych PL2724720T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/408,299 US10022339B2 (en) 2006-04-21 2006-04-21 Compositions and methods useful for treatment of respiratory illness
EP07735601.2A EP2032129B1 (en) 2006-04-21 2007-04-20 Compositions of phenylephrine useful for treatment of respiratory illness
EP13187884.5A EP2724720B1 (en) 2006-04-21 2007-04-20 Compositions of phenylephrine useful for treatment of respiratory illness

Publications (1)

Publication Number Publication Date
PL2724720T3 true PL2724720T3 (pl) 2018-09-28

Family

ID=38620207

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13187884T PL2724720T3 (pl) 2006-04-21 2007-04-20 Kompozycje fenylefryny użyteczne do leczenia choroby dróg oddechowych

Country Status (11)

Country Link
US (7) US10022339B2 (pl)
EP (2) EP2032129B1 (pl)
JP (1) JP2009534371A (pl)
CN (1) CN101495110B (pl)
AU (1) AU2007242418B2 (pl)
BR (1) BRPI0710485B8 (pl)
CA (1) CA2650033C (pl)
ES (1) ES2667331T3 (pl)
MX (1) MX338338B (pl)
PL (1) PL2724720T3 (pl)
WO (1) WO2007122580A2 (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
CN102036658A (zh) * 2008-05-23 2011-04-27 香港大学 治疗流感的联合疗法
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
US9308211B2 (en) * 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) * 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
HUE038399T2 (hu) * 2010-07-12 2018-10-29 Sanofi Aventis Deutschland Brómhexint tartalmazó vizes kompozíció
MX361099B (es) 2013-02-13 2018-11-27 Procter & Gamble Medicamento con sabor a anís.
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10993921B2 (en) 2013-10-03 2021-05-04 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
LT3069733T (lt) * 2013-11-13 2022-11-25 National Defense Education And Research Foundation Nauja acetaminofeno junginio sudėtis be šalutinio poveikio kepenims
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN105982897B (zh) * 2015-02-13 2021-01-01 北京韩美药品有限公司 液体制剂、其制备方法及应用
US11213480B1 (en) 2015-08-06 2022-01-04 Hikma Pharmaceuticals International Limited Phenylephrine hydrochloride ready-to-use solution
CA3034640A1 (en) 2016-08-25 2018-03-01 Imprimis Pharmaceuticals, Inc. Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
MX2020012233A (es) 2018-05-16 2021-01-29 Bayer Healthcare Llc Formula de suspension de alta concentracion para medicamentos en capsula de gel blanda para resfriado y gripe.
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
CN108434097A (zh) * 2018-06-22 2018-08-24 南京济群医药科技股份有限公司 一种稳定的含盐酸曲普利啶口服溶液剂及其制备方法
CN109044968B (zh) * 2018-10-18 2020-12-01 云南大唐汉方制药股份有限公司 氨酚右美肾素口服液及其制备方法
CN109045003B (zh) * 2018-10-18 2020-12-01 云南大唐汉方制药股份有限公司 氨酚拉明肾素口服液及其制备方法
CN109010341A (zh) * 2018-10-29 2018-12-18 南京济群医药科技股份有限公司 一种含有氢溴酸右美沙芬的复方口服溶液及其制备方法
CN110327339A (zh) * 2019-08-07 2019-10-15 北京博达绿洲医药科技研究有限公司 一种复方右美沙芬口服溶液及其制备方法和用途
CN110279695B (zh) * 2019-08-07 2022-04-08 北京博智绿洲医药科技有限公司 一种治疗流涕、鼻塞等感冒症状的药物组合物及其制备方法和用途
CN112076183A (zh) * 2020-08-28 2020-12-15 北京博达绿洲医药科技研究有限公司 包含盐酸去氧肾上腺素液体组合物
JP2023543441A (ja) * 2020-09-17 2023-10-16 アデュルサ・セラピューティクス・コーポレーション 呼吸器ウイルスによって引き起こされる疾患を阻害する方法
AU2022201576A1 (en) * 2022-03-08 2023-09-28 Aft Pharmaceuticals Limited Medication

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB836747A (en) 1957-07-31 1960-06-09 Upjohn Co Improvements in or relating to steroidal compounds and compositions and the preparation thereof
GB895495A (en) 1960-01-20 1962-05-02 Boots Pure Drug Co Ltd Amino-acetamidoximes and their preparation
US3169092A (en) * 1963-09-26 1965-02-09 Richardson Merrell Inc Stabilization of amines by tartrazine and bisulfite
US3293045A (en) * 1963-10-18 1966-12-20 Pfizer & Co C Increasing the flavor strength of anethole, cinnamaldehyde and methyl salicylate with maltol
GB1121358A (en) 1965-10-21 1968-07-24 Bristol Myers Co Aerosol manufacture
US3480185A (en) * 1966-06-20 1969-11-25 Johnson & Johnson Charged effervescing agent and medicament dispensing metering valve-actuated aerosol container producing a dose of medicament and carbonation in water
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPH0780760B2 (ja) 1986-07-28 1995-08-30 ライオン株式会社 安定化されたフエニレフリン系液剤
EP0306469B1 (en) 1987-09-04 1992-03-04 The Procter & Gamble Company Psyllium-containing filling compositions
ATE92276T1 (de) 1989-03-16 1993-08-15 Procter & Gamble Psyllium enthaltende kekse mit hohem fasergehalt.
JP3256997B2 (ja) 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5178025A (en) 1990-08-31 1993-01-12 Innovative Medical Engineering, Inc. Tiltable lift seat devices
US5196436A (en) 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US5296209A (en) 1992-01-17 1994-03-22 Colgate Palmolive Company Pet chew product having oral care properties
EP0662840A1 (en) * 1992-10-09 1995-07-19 The Procter & Gamble Company Pharmaceutical compositions and methods for treating cold symptoms
US5480674A (en) 1993-06-25 1996-01-02 Firmenich Incorporated Flavor composition for an oral electrolyte rehydration solution
JP3643604B2 (ja) 1993-09-17 2005-04-27 セイコーインスツル株式会社 内面研削盤における研削方法
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
JPH09286726A (ja) 1996-04-18 1997-11-04 Takeda Chem Ind Ltd 経口液剤
JPH09286723A (ja) 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤
JPH09286724A (ja) 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 経口用安定液剤
US5660833A (en) * 1996-06-05 1997-08-26 Medenica; Rajko D. Anti-tussive composition
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
JPH10167988A (ja) 1996-10-09 1998-06-23 Takeda Chem Ind Ltd 経口液剤
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
DE69815003T2 (de) * 1997-09-10 2004-04-01 Takeda Chemical Industries, Ltd. Stabilisierte pharmazeutische Zusammensetzung
ATE219657T1 (de) 1998-01-30 2002-07-15 Novartis Consumer Health Sa Nasale lösungen
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6287597B1 (en) * 1999-03-12 2001-09-11 Carter-Wallace, Inc. Antihistaminic/decongestant compositions
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
PT1283043E (pt) 2000-05-17 2008-02-07 Senju Pharma Co Solução oftálmica
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
JP2002212107A (ja) 2001-01-22 2002-07-31 Taisho Pharmaceut Co Ltd 局所適用組成物
BR0211794A (pt) 2001-07-31 2004-11-03 Wyeth Corp Composição farmacêutica e método para mascarar o sabor de pelo menos um composto farmaceuticamente ativo de sabor desagradável
US20030026826A1 (en) 2001-07-31 2003-02-06 Cherukuri Subraman Rao Sugar-free chewy products and protein-based chewy products and methods for making the same
US20040132827A1 (en) * 2001-10-26 2004-07-08 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
US20030083354A1 (en) * 2001-10-26 2003-05-01 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
WO2003045331A2 (en) * 2001-11-29 2003-06-05 Emisphere Technologies, Inc. Formulations for oral administration of cromolyn sodium
US7101572B2 (en) 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US20030170371A1 (en) 2002-01-10 2003-09-11 Cargill, Inc. High fat/fiber composition
JP2005519923A (ja) 2002-02-04 2005-07-07 ファルマシア・コーポレーション シクロオキシゲナーゼ−２選択的阻害剤ならびに風邪および咳止め薬の組み合わせを用いる風邪および咳の治療ならびにそれらの組成物
EP1559433A4 (en) 2002-10-22 2009-11-04 Dainippon Sumitomo Pharma Co STABILIZED COMPOSITION
US20050214349A1 (en) 2002-10-30 2005-09-29 Li Nie Extruded gluten based pet chew bodies
US20060193959A1 (en) 2002-10-30 2006-08-31 Li Nie Low calorie injection molded starch-based pet chew bodies
US20040259955A1 (en) 2002-11-08 2004-12-23 Boehringer Ingelheim International Gmbh New pharmaceutical compositions containing ambroxol and isopropamide iodide
DE10261061A1 (de) 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
JP2004217596A (ja) 2003-01-17 2004-08-05 Taisho Pharmaceut Co Ltd 点眼剤組成物
US20040162273A1 (en) 2003-01-23 2004-08-19 The Procter & Gamble Company Powder pharmaceutical compositions
JP2004300138A (ja) 2003-03-18 2004-10-28 Takeda Chem Ind Ltd 安定化された経口固形製剤
WO2004084637A1 (en) 2003-03-24 2004-10-07 Council Of Scientific And Industrial Research A high fibre biscuit composition and a process for preparing the same
JP4473539B2 (ja) 2003-08-12 2010-06-02 エスエス製薬株式会社 医薬組成物
US7118772B2 (en) 2003-09-18 2006-10-10 General Mills, Inc. Inulin infused fruit and method of preparation
DE10358213A1 (de) 2003-12-12 2005-07-28 Clariant Gmbh Polyethylenglykol und dessen Herstellung
US20050266032A1 (en) 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006022996A2 (en) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20060039973A1 (en) 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including water soluble dietary fiber
US20060148837A1 (en) 2005-01-04 2006-07-06 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20060188450A1 (en) * 2005-02-24 2006-08-24 Tim Clarot System and method for suppressing a cough
DE102006030757A1 (de) 2005-07-18 2007-02-01 Carl Zeiss Smt Ag Polarisationsoptimiertes Beleuchtungssystem
US20070098785A1 (en) * 2005-11-02 2007-05-03 Tim Clarot Medicant delivery system and device
WO2007089652A2 (en) * 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
US8940796B2 (en) 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070254027A1 (en) 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20080014275A1 (en) 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
US20080014274A1 (en) 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
WO2008033155A1 (en) 2006-09-15 2008-03-20 Auriga Laboratories, Inc. Kits for prevention and treatment of rhinitis
CN107811999A (zh) 2013-02-04 2018-03-20 Aft制药有限公司 包括苯肾上腺素和扑热息痛的组合药剂

Also Published As

Publication number Publication date
CN101495110A (zh) 2009-07-29
MX338338B (es) 2015-07-07
BRPI0710485B1 (pt) 2020-04-28
BRPI0710485B8 (pt) 2021-05-25
US20210353562A1 (en) 2021-11-18
BRPI0710485A8 (pt) 2018-01-02
AU2007242418A1 (en) 2007-11-01
US11077074B2 (en) 2021-08-03
CN101495110B (zh) 2013-02-20
WO2007122580A3 (en) 2009-03-19
JP2009534371A (ja) 2009-09-24
EP2032129A2 (en) 2009-03-11
US20180338933A1 (en) 2018-11-29
CA2650033A1 (en) 2007-11-01
ES2667331T3 (es) 2018-05-10
US20180360779A1 (en) 2018-12-20
US20180360780A1 (en) 2018-12-20
US10022339B2 (en) 2018-07-17
US20180360781A1 (en) 2018-12-20
EP2724720A1 (en) 2014-04-30
US10772848B2 (en) 2020-09-15
BRPI0710485A2 (pt) 2011-08-16
CA2650033C (en) 2013-07-02
MX2008013258A (es) 2009-03-06
EP2724720B1 (en) 2018-02-21
AU2007242418B2 (en) 2013-04-11
EP2032129B1 (en) 2014-01-29
US11083697B2 (en) 2021-08-10
US20070249566A1 (en) 2007-10-25
US20180360778A1 (en) 2018-12-20
WO2007122580A2 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
PL2724720T3 (pl) Kompozycje fenylefryny użyteczne do leczenia choroby dróg oddechowych
GB2426023B (en) Structured composite compositions for treatment of subterranenan wells
GB2438083B (en) Improvements relating to respiratory masks
IL230335A (en) A drug used to treat cartilage disease
EP2282795A4 (en) TREATMENT OF RESPIRATORY DISEASES
EP2068864A4 (en) THERAPEUTIC USES OF UROLITHINS
PL2012765T3 (pl) Płynne kompozycje zawierające fenylefrynę i acetaminofen oraz ich zastosowanie do leczenia chorób układu oddechowego
EP1996612A4 (en) COMPOSITIONS FOR THE TREATMENT OF CANCER
AU311197S (en) Respiratory mask elbow
AU311200S (en) Respiratory mask elbow
GB0907684D0 (en) Process for preparation of alkoxysilanes
ZA200806808B (en) Treatment of stressed patients
AU311113S (en) Elbow for respiratory mask
GB0602768D0 (en) Treatment of muscular dystrophy
ZA201000225B (en) Treatment of depression
EP2056830A4 (en) SPECIAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME
GB0720429D0 (en) Treatment of contaminated gases
GB0700179D0 (en) Use of epoxidised compounds
ZA200807306B (en) Treatment of acute respiratory distress syndrome
EP2117586A4 (en) TREATMENT OR PROPHYLAXIS OF ASTHMA
HU0500947D0 (en) Composition for treatment of paradontosis
GB0623740D0 (en) Treatment of disease
GB0602767D0 (en) Treatment of muscular dystrophy
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
EP1998727A4 (en) HERB-BASED COMPOSITION FOR THE TREATMENT OF INFECTIONS CAUSED BY DERMATOPHYTES